Fish assay for EML4 and ALK fusion in lung cancer

Details for Australian Patent Application No. 2009215168 (hide)

Owner The Brigham and Women's Hospital, Inc. Dana-Farber Cancer Institute

Inventors Janne, Pasi; Murphy, Carly; Lee, Charles

Agent Pizzeys

Pub. Number AU-A-2009215168

PCT Pub. Number WO2009/102446

Priority 61/065,422 12.02.08 US

Filing date 12 February 2009

Wipo publication date 20 August 2009

International Classifications

G01N 33/533 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with fluorescent label

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/52 (2006.01) Investigating or analysing materials by specific methods not covered by groups -

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

30 September 2010 PCT application entered the National Phase

  PCT publication WO2009/102446 Priority application(s): WO2009/102446

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009215171-Introducer for endovascular grafts and stents

2009215163-Curve forming apparatus and curvable stent graft